Tesamorelin + Ipamorelin
Also known as: Tesa/Ipa
Pre-mixed blend of Tesamorelin (a stabilized GHRH(1-44) analog) and Ipamorelin (a selective ghrelin-receptor agonist). Tesamorelin is FDA-approved as Egrifta for HIV-associated lipodystrophy; Ipamorelin is not FDA-approved. The blend itself is NOT clinically validated — no controlled trial has tested Tesamorelin co-administered with Ipamorelin. Evidence is inferred from the individual components.
Pricing for Tesamorelin + Ipamorelin
Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.
COAs for Tesamorelin + Ipamorelin
24 third-party tests across 9 vendors. Each card links to the full report.
For
Tesamorelin + Ipamorelin
by OROS Research· batch OR-LPTESIPA20-426-B3
For
Tesamorelin + Ipamorelin
by Real Peptides· batch Green Cap
For
Tesamorelin + Ipamorelin
by Glacier Aminos· batch TEIPGA-03
For
Tesamorelin + Ipamorelin
by Mile High Compounds· batch TIB-013-MH-01
For
Tesamorelin + Ipamorelin
by BioLongevity Labs· batch cmojb6vdj016gkirxu9lwgnrm
For
Tesamorelin/Ipamorelin Blend
by Simple Peptide· batch TESIPA 10222025-J
For
Tesamorelin + Ipamorelin
by Simple Peptide· batch TESIPA09022025-01
For
Tesamorelin With Ipamorelin
by BioLongevity Labs· batch cmojb75d8018tkirxk61zrkju
For
Tesamorelin With Ipamorelin
by BioLongevity Labs· batch cmojb7df101aqkirxtb3uwlv6
For
TESA+IPA (Tesamorelin + Ipamorelin)
by Peptide Plugs· batch 123-04-DK
For
Tesamorelin + Ipamorelin
by Peptide Supply Co.· batch TSM13IP304202026
For
Tesamorelin + Ipamorelin
by Peptide Plugs· batch 116-GGB
For
Tesamorelin + Ipamorelin
by Profound Aminos· batch cmojb89f401hykirx57qa12c0
For
Tesamorelin with Ipamorelin
by BioLongevity Labs· batch cmojb7g1j01bdkirx20z0qp8x
Purity not on file
For
Tesamorelin/Ipamorelin blend
by Skye Peptides· batch 2X26-102-001
Purity not on file
For
Tesamorelin/Ipamorelin blend
by Skye Peptides· batch 2X26-102-001
Purity not on file
For
Tesamorelin/Ipamorelin blend
by Skye Peptides· batch 2X26-102-001
Purity not on file
For
Tesamorelin / Ipamorelin blend
by Skye Peptides· batch 2X26-105-001
Purity not on file
For
Tesamorelin + Ipamorelin
by BioLongevity Labs· batch 29-3-45959
Purity not on file
For
Tesamorelin/Ipamorelin blend
by Skye Peptides· batch 2x25-102-002
Purity not on file
For
Tesamorelin/Ipamorelin blend
by Skye Peptides· batch 2x25-102-002
Purity not on file
For
Tesamorelin With Ipamorelin
by BioLongevity Labs· batch cmojb759e018skirxwhrtkpzf
Purity not on file
For
Tesamorelin + Ipamorelin
by Skye Peptides· batch 2X26-105-001
Purity not on file
For
Tesamorelin + Ipamorelin
by Skye Peptides· batch 2X26-105-002
2 citations indexed for Tesamorelin + Ipamorelin
Study · 2023
Weight and BMI Changes Following Initiation of Emtricitabine/Tenofovir Alafenamide Co-Formulated with Darunavir or Co-Administered with Dolutegravir in Overweight or Obese, ART-Naïve People Living with HIV-1
Introduction Integrase strand transfer inhibitor-based regimens (eg, containing dolutegravir [DTG]) are associated with weight/body mass index (BMI) increases among people living with HIV-1 (PLWH).
Study · 2023
Incidence of cardiometabolic outcomes among people living with HIV-1 initiated on integrase strand transfer inhibitor versus non-integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United States
Introduction Integrase strand transfer inhibitor (INSTI)-containing antiretroviral therapy (ART) has been associated with weight gain, though there is limited information on associations between ART-related weight gain and cardiometabolic outcomes among people living with HIV-1 (PLWH).